US FDA warns CanaRx for selling unapproved, misbranded and unsafe imported drugs to unsuspecting Americans



The U.S. Food and Drug Administration posted a warning letter to CanaRx for facilitating the distribution of unapproved new drugs and misbranded drugs to U.S. consumers. These drugs are potentially dangerous to U.S. consumers.

CONTINUE READING ON www.fda.gov

                   

Related News

Loading...